학술논문

GB7208 is a novel, highly potent and selective CNS-penetrant BTK inhibitor for neuroinflammatory and neurodegenerative diseases
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; OCT 2022, 28 3_SUPPL, p607-p608, 2p. Supplement: 3_
Subject
Language
English
ISSN
14770970